Evidence map›Paper›PMID 40756109›Full record

ArticleFrontiers in oncology2025

Case Report: Surgery for proximal gastric cancer with splenic artery aneurysm: approach and complication mangement.

Xuerui Shu, Fu Xiang, Xuedong Xu, Lin Jing, Riyu Tian, Yiao Xia

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xuerui Shu *The First Affiliated Hospital of Dalian Medical University, Department of General Surgery, Dalian, Liaoning, China.
Fu Xiang *The First Affiliated Hospital of Dalian Medical University, Department of General Surgery, Dalian, Liaoning, China.
Xuedong XuThe First Affiliated Hospital of Dalian Medical University, Department of General Surgery, Dalian, Liaoning, China.
Lin JingThe First Affiliated Hospital of Dalian Medical University, Department of General Surgery, Dalian, Liaoning, China.
Riyu TianThe First Affiliated Hospital of Dalian Medical University, Department of General Surgery, Dalian, Liaoning, China.
Yiao XiaThe First Affiliated Hospital of Dalian Medical University, Department of General Surgery, Dalian, Liaoning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Gastric cancer surgery is gradually shifting from extensive, standardized operations to individual, precise procedures. The two surgical options for proximal gastric cancer are total gastrectomy and proximal gastrectomy. In recent years, proximal gastrectomy has gained wider acceptance in clinical practice, with increasingly relaxed indications. The present report describes an extremely rare clinical case of proximal gastric cancer. Case presentation: A 64-year-old man with proximal gastric cancer after splenic artery aneurysm embolization underwent proximal gastrectomy with preservation of the short gastric vessels to retain the spleen. Despite the difficult treatment process, the patient achieved a favorable outcome at the 10-month follow-up. Conclusion: This report provides a valuable reference for the individualized treatment of proximal gastric cancer, highlighting the importance of considering potential complications such as external pressure from anatomical anomalies in the postoperative management of gastric cancer.

Indexed as

gastric tubelaparoscopic proximal gastrectomyproximal gastric cancerRoux-en-Y gastrojejunostomyshort gastric vesselsspleen preservation

Identifiers

PMID40756109
PMCPMC12313472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.